Johns Hopkins University 5U01CA274631-03

Matching genotypes with personalized therapies: Development of a decision support infrastructure to augment the value of precision medicine

NIH awarded Johns Hopkins University approximately $407,737 to develop an automated precision oncology decision support system to enhance personalized cancer therapies and clinical outcomes over a four-year period.

Description

This NIH-funded project at Johns Hopkins University focuses on creating a scalable, automated decision support platform for precision oncology, aiming to improve treatment personalization and clinical outcomes. The project aims to develop a fully automated precision oncology decision support system that unifies mutation characterization, provides links to targeted therapies, and integrates into clinical decision-making. The project involves advanced data integration, natural language processing, and clinical application in oncology. The project duration is from August 1, 2023, to July 31, 2027.

View original record